MedPath

Contribution Of Nuclear Magnetic Resonance Imaging In The Study Of Diabetic Cardiomyopathy

Not Applicable
Conditions
Diabetic
Cardiomyopathy
Interventions
Other: NUCLEAR MAGNETIC RESONANCE IMAGING
Registration Number
NCT01295385
Lead Sponsor
Assistance Publique Hopitaux De Marseille
Brief Summary

Diagnosis of diabetic cardiomyopathy is then retained, supposing a change in the coronary microcirculation linked to an endothelial dysfunction. Abnormalities of the myocardial metabolism is frequently associated. It is regrettably about a hypothesis difficult to verify with current medical techniques.This deficiency being not only harmful to the diagnosis, but also to the assessment of the efficiency of the medical treatment on the myocardial metabolism and the endothelial function. Techniques of nuclear magnetic resonance offer interesting perspectives.

Detailed Description

These techniques allow in this context:

1. to quantify the myocardial blood flow at rest and after "cold pressor test" in a population of healthy volunteers. The myocardial blood flow will be obtained by estimating myocardial blood flow at the venous coronary sinus site. This allows us to quantify a possible endothelial dysfunction in a reproducible way. No MRI study in diabetic patients has ever been led until now with this technique.

2. to estimate the metabolic and structural abnormalities in this population, with particularly:

* Quantification of the myocardial metabolism in vivo by spectrometry of phosphorus 31.

* Structural abnormalities: become integrated into the description of diabetic cardiomyopathy.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
25
Inclusion Criteria
  • more than 18 years old
  • patient type 2 diabetes affects taken care more than 5 years to Timone Hospital
  • patient with a diabetic cardiomyopathy
  • informed and consented
Exclusion Criteria
  • less than 18 years
  • Pregnant woman
  • patient type 1 diabetes affects
  • patient presents a cardiomyopathy mixed (no diabetic)
  • patients presents an arrhythmia ventriculaire or above - ventriculaire
  • Unstable hémodynamique patients

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
patients with a diabetic cardiomyopathyNUCLEAR MAGNETIC RESONANCE IMAGING-
healthy volunteersNUCLEAR MAGNETIC RESONANCE IMAGING-
Primary Outcome Measures
NameTimeMethod
To quantify the myocardial blood flow at rest and after "cold pressor test" in a population of healthy volunteers12 months

The myocardial blood flow will be obtained by estimating myocardial blood flow at the venous coronary sinus site. This allows us to quantify a possible endothelial dysfunction in a reproducible way. No MRI study in diabetic patients has ever been led until now with this technique.

Secondary Outcome Measures
NameTimeMethod
To estimate the metabolic and structural abnormalities in this population12 months

* Quantification of the myocardial metabolism in vivo by spectrometry of phosphorus 31 which allows to estimate the energy state of the heart by analyzing the phosphorous metabolites with high energy involved in the myocardial energetic metabolism.

* Structural abnormalities: evaluation of the fibrosis and the collagenic deposits by T1 mapping and measurement of relaxation T2 as well as the study of the late enhancement of gadolinium. These structural abnormalities become integrated into the description of diabetic cardiomyopathy.

Trial Locations

Locations (1)

Assistance Publique - Hopitaux de Marseille

🇫🇷

Marseille, France

© Copyright 2025. All Rights Reserved by MedPath